Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jonathan Monson

Jonathan Monson is recorded as Head of Investor Relations and CFO at Boston Scientific Corp (BSX). Boston Scientific Corp reported in an 8-K filed April 23, 2025 that Jonathan Monson was appointed Executive Vice President and Chief Financial Officer, effective June 30, 2025. Boston Scientific Corp reported in an 8-K filed January 31, 2024 that Jonathan Monson was appointed Senior Vice President, Investor Relations, effective March 1, 2024. The proxy statement of Boston Scientific Corp reports total compensation of $6,083,679 for Jonathan Monson in fiscal 2025, including a base salary of $591,848. Jonathan Monson has spoken on 4 earnings calls across 1 company, most recently for Boston Scientific Corp on October 22, 2025.

“On April 23, 2025, Boston Scientific Corporation (the "Company") announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025, and that Jonathan Monson, who currently serves as Senior Vice President, Investor Relations, has been promoted to Executive Vice President and Chief Financial Officer of the Company effective as of June 30, 2025.”
Boston Scientific Corp Form 8-K, filed April 23, 2025 · Read the filing
“the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) appointed Jonathan Monson as Senior Vice President, Investor Relations, effective March 1, 2024.”
Boston Scientific Corp Form 8-K, filed January 31, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Boston Scientific Corp

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Boston Scientific Corp (BSX) $591,848 $6,083,679

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.